Latest Regulatory News

Energy Transition Minerals Ltd (ETM) reported key progress in its December 2025 quarter, including legal developments for its Greenland rare earth project, advancing a strategic mine acquisition in Spain, and moves toward a US Nasdaq listing.

EMVision Medical Devices reports strong progress in its emu™ Brain Scanner clinical trials, expanding recruitment across seven leading stroke hospitals and introducing new software features to enhance scan quality.

Viking Mines has completed a cutting-edge drone survey at its Linka Tungsten Project, integrating 1970s data with modern technology to fast-track exploration and permitting.

Electro Optic Systems (EOS) reports a record $459 million contract backlog, major new defence contracts including a $120 million laser weapon deal, and a strategic acquisition to boost counter-drone capabilities.

Canyon Resources advances steadily on its Minim Martap Bauxite Project with mining operations set to begin in February 2026 and a strong equity raise underpinning development.

EV Resources has confirmed exceptional grades of antimony, copper, and silver at its Dollar Antimony project in Nevada, signalling a promising polymetallic vein system and advancing its strategy to supply critical minerals domestically in the US.

Energy Resources of Australia (ERA) reports ongoing legal challenges over the Jabiluka Mineral Lease and a compulsory acquisition court hearing, alongside delays in key rehabilitation works at the Ranger Project Area.

Tivan Limited has reported fresh copper-gold mineralisation at its Turiscai Project in Timor-Leste, alongside nearing completion of strategic acquisitions at Baucau and Ossu. These developments mark significant progress in the company’s regional exploration ambitions.

Orezone Gold Corporation has announced its acquisition of the Casa Berardi gold mine in Quebec, Canada, marking a strategic expansion into a Tier 1 mining jurisdiction and significantly boosting its production profile.

Orezone Gold Corporation has announced a transformative acquisition of the Casa Berardi gold mine in Quebec, marking its entry into a Tier 1 mining jurisdiction and significantly boosting production and cash flow.

Actinogen Medical has locked in a $4.3 million tranche of non-dilutive funding to support its pivotal Alzheimer’s disease trial, reinforcing its financial position as it nears critical interim and final results.

Singular Health Group has advanced its U.S. commercial footprint with the deployment of 500 new licences under its PNS contract and secured FDA clearance for its cloud-based 3DICOM MD® platform, positioning the company for significant growth.